Acute lymphoblastic leukaemia (ALL) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051101

Acute lymphoblastic leukaemia (ALL) restriction and item codes

Do not share these attachments externally. See Freedom of Information - Information Publication Scheme.

$\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png$ PBS ALL blinatumomab/inotuzumab restriction and item codes

$\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png$ PBS ALL imatinib/dasatinib/ponatinib restriction and item codes

Contact details

PBS Complex Drugs Programs team

Forms

Acute lymphoblastic leukaemia - blinatumomab initial (induction) authority application (PB210)

Acute lymphoblastic leukaemia - inotuzumab initial (induction) authority application (PB269)

Acute lymphoblastic leukaemia – first line – dasatinib initial PBS authority application (PB271)

Acute lymphoblastic leukaemia – second line - dasatinib initial PBS authority application (PB077)

Acute lymphoblastic leukaemia - ponatinib - initial authority application form (PB169)

Services Australia website

Acute lymphoblastic leukaemia

External websites